Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

"""ChIP Seq RA CD"""

Financiado

Cerrado

Identification of regulator variants in Rheumatoid Arthritis and Crohn s Disease

Rheumatoid Arthritis (RA) and Crohn’s disease (CD) are two common chronic autoimmune and complex diseases where individual susceptibility is determined by a combination of environmental and genetic factors. Almost all of the ~100... ver más

31/05/2015

ULIEGE

257K€

Presupuesto del proyecto: 257K€

Líder del proyecto

UNIVERSITE DE LIEGE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-05-31 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

ULIEGE

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

GENTOPHEN Linking genotype to phenotype for the rheumatoid arthritis s... 45K€ Cerrado

FERAL Functional characterization of a novel rheumatoid arthritis... 172K€ Cerrado

SAF2011-29635 CAMBIOS EN LA METILACION DEL DNA EN ENFERMEDADES REUMATICAS... 206K€ Cerrado

CD40RA Identification of functional common and rare variants in the... 241K€ Cerrado

PGC2018-097573-A-I00 EPITRANSCRIPTOMA, LNCRNAS Y VARIANTES DE RIESGO: IMPLICACION... 218K€ Cerrado

RTC-2015-3562-1 Desarrollo y Validación clínica de un sistema de análisis de... 49K€ Cerrado

Líder del proyecto

UNIVERSITE DE LIEGE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 257K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Rheumatoid Arthritis (RA) and Crohn’s disease (CD) are two common chronic autoimmune and complex diseases where individual susceptibility is determined by a combination of environmental and genetic factors. Almost all of the ~100 risk alleles discovered through recent genetic studies fall in non-coding region and have an elusive function. We hypothesize that risk alleles impact gene regulation by altering regulatory elements (e.g. enhancers) controlling the expression levels of genes within the same pathogenic pathway. The cell-specific variation in regulatory element (RE) activity can be identified by assaying histone modifications which correlate with chromatin states and DNA accessibility. Recently, assaying these histone modifications has become possible with ChiP seq methods, which applies high-throughput sequencing to identify genomic segments bound to antibodies to specific histone modifications. However to identify the REs impacted by risk loci, it is first necessary to determine the cells type (CT) affected by these risk loci; these cell types are not obvious in autoimmune diseases. Exploiting data on genome-wide histone marks in a library of immune-CT, we will develop a statistical method to identify the likely key pathogenic cells type by looking for immune-CTs specifically enriched in active REs containing risk loci. Subsequently, we will develop an approach to determine the cell specific REs impacted by risk loci and establish putative regulatory variant within of REs and associated with these complex disorders. I will develop this approach in my Outgoing Host Institute (Harvard Medical School) using RA as model, and will then apply it to CD in my Return Host Institute (University of Liege) where I pursue my research on the effect of regulatory risk alleles on the cell specific gene expression. This proposal will allow the discovery of new drug targets that can ultimately result in novel specific therapies for RA and CD patients.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores